GEORGE YANCOPOULOS - 21 Jun 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**George D. Yancopoulos
Issuer symbol
REGN
Transactions as of
21 Jun 2021
Net transactions value
-$43,112,141
Form type
4
Filing time
23 Jun 2021, 16:02:45 UTC
Next filing
06 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 +82,108 $0.000000 82,108 12 Jan 2021 By Trust for Chldn. F1
transaction REGN Common Stock Sale $393,273 -738 -0.9% $532.89 81,370 21 Jun 2021 By Trust for Chldn. F1, F2, F3
transaction REGN Common Stock Sale $3,999,248 -7,494 -9.2% $533.66 73,876 21 Jun 2021 By Trust for Chldn. F1, F2, F4
transaction REGN Common Stock Sale $4,401,977 -8,236 -11% $534.48 65,640 21 Jun 2021 By Trust for Chldn. F1, F2, F5
transaction REGN Common Stock Sale $2,225,007 -4,154 -6.3% $535.63 61,486 21 Jun 2021 By Trust for Chldn. F1, F2, F6
transaction REGN Common Stock Sale $2,021,042 -3,768 -6.1% $536.37 57,718 21 Jun 2021 By Trust for Chldn. F1, F2, F7
transaction REGN Common Stock Sale $3,567,580 -6,636 -11% $537.61 51,082 21 Jun 2021 By Trust for Chldn. F1, F2, F8
transaction REGN Common Stock Sale $2,621,613 -4,868 -9.5% $538.54 46,214 21 Jun 2021 By Trust for Chldn. F1, F2, F9
transaction REGN Common Stock Sale $1,784,116 -3,306 -7.2% $539.66 42,908 21 Jun 2021 By Trust for Chldn. F1, F2, F10
transaction REGN Common Stock Sale $4,378,400 -8,099 -19% $540.61 34,809 21 Jun 2021 By Trust for Chldn. F1, F2, F11
transaction REGN Common Stock Sale $10,780,612 -19,911 -57% $541.44 14,898 21 Jun 2021 By Trust for Chldn. F1, F2, F12
transaction REGN Common Stock Sale $5,703,109 -10,514 -71% $542.43 4,384 21 Jun 2021 By Trust for Chldn. F1, F2, F13
transaction REGN Common Stock Sale $1,236,164 -2,276 -52% $543.13 2,108 21 Jun 2021 By Trust for Chldn. F1, F2, F14
holding REGN Common Stock 987,483 21 Jun 2021 Direct
holding REGN Common Stock 5,845 21 Jun 2021 By 401(k) Plan
holding REGN Common Stock 211,585 21 Jun 2021 by 2019 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Class A Stock Gift $0 +14,000 $0.000000 14,000 15 Apr 2021 Common Stock 14,000 By Tr. for Daughter F15, F16, F17
transaction REGN Class A Stock Gift $0 -14,000 -100% $0.000000* 0 15 Apr 2021 Common Stock 14,000 by Daughter F15, F16, F18
transaction REGN Class A Stock Gift $0 -5,383 -100% $0.000000* 0 15 Apr 2021 Common Stock 5,383 by Son F15, F16, F18
transaction REGN Class A Stock Gift $0 +5,383 $0.000000 5,383 15 Apr 2021 Common Stock 5,383 by Trust for Son F15, F16, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As investment trustee of trusts for the benefit of the reporting person's children.
F2 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F3 Represents volume-weighted average price of sales of 738 shares of Company stock on June 21, 2021 at prices ranging from $532.56 to $532.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 7,494 shares of Company stock on June 21, 2021 at prices ranging from $533.14 to $533.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 8,236 shares of Company stock on June 21, 2021 at prices ranging from $534.01 to $534.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 4,154 shares of Company stock on June 21, 2021 at prices ranging from $535.05 to $535.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 3,768 shares of Company stock on June 21, 2021 at prices ranging from $536.02 to $536.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 6,636 shares of Company stock on June 21, 2021 at prices ranging from $537.05 to $537.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 4,868 shares of Company stock on June 21, 2021 at prices ranging from $538.01 to $538.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 3,306 shares of Company stock on June 21, 2021 at prices ranging from $539.14 to $539.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F11 Represents volume-weighted average price of sales of 8,099 shares of Company stock on June 21, 2021 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F12 Represents volume-weighted average price of sales of 19,911 shares of Company stock on June 21, 2021 at prices ranging from $541.00 to $541.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F13 Represents volume-weighted average price of sales of 10,514 shares of Company stock on June 21, 2021 at prices ranging from $542.00 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F14 Represents volume-weighted average price of sales of 2,276 shares of Company stock on June 21, 2021 at prices ranging from $543.01 to $543.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
F15 Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
F16 These shares of Class A Stock are presently convertible and such conversion feature does not expire.
F17 These shares of Class A Stock are held in a trust for the benefit of the reporting person's child, of which the reporting person is trustee.
F18 These shares of Class A Stock were held in custody for the benefit of the reporting person's child.